8 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 8 |
Follow HIV Infection: new trials by email Literature Review of HIV Infection trials Research Report on HIV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Triple vs. Double Therapy in naïves HIV-Infected Patients Randomize - HIV Infection | Phase 4 | Unknown | Hospitales Universitarios Virgen del Rocío | 70 | 2020-03-10 | 2020-08-18 |
| RPV+DRV/Cobi Dual Therapy in Subjects With HIV Controlled Infection Rilpivirine + darunavir/cobicistat - HIV Infection | Phase 4 | Unknown | A.O. Ospedale Papa Giovanni XXIII | 1609 | 2017-02-01 | 2019-08-22 |
| Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients PCV13, PPV23 - HIV Infection | Phase 4 | Unknown | Aghia Sophia Children's Hospital of Athens | 40 | 2015-12-01 | 2017-02-02 |
| RAltegravir Switch STudy: Effects on Endothelial Recovery raltegravir - HIV Infection, Endothelial Dysfunction | Phase 4 | Unknown | UMC Utrecht | 24 | 2012-01-01 | 2013-12-18 |
| Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT) Protease Inhibitor, Standard-of-care Antiretroviral therapy - HIV Infection, Acquired Immunodeficiency Syndrome | Phase 4 | Unknown | Medical Research Council | 587 | 2008-11-01 | 2012-10-10 |
| Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients mycophenol mofetil (MMF, Cellcept®) 500 mg BID - HIV Infection, Atherosclerosis | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 90 | 2005-04-01 | 2009-07-22 |
| Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study) mycophenol mofetil (MMF, Cellcept®) 500 mg BID - HIV Infection | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 90 | 2005-04-01 | 2009-07-22 |
| Once Daily 3TC, Efavirenz and ddI for HIV Infection once daily minimum 3-drug regimen of anti-retroviral medications - HIV Infection, AIDS | Phase 4 | Unknown | 407 Doctors | 120 | 2004-05-01 | 2005-10-25 |
HIV Infections (8) · Acquired Immunodeficiency Syndrome (2) · Atherosclerosis (1) · Immune System Diseases (1) · RNA Virus Infections (1) · Sexually Transmitted Diseases, Viral (1) · Virus Diseases (1)
Blood-Borne Infections (8) · Communicable Diseases (8) · Genital Diseases (8) · Immunologic Deficiency Syndromes (8) · Infections (8) · Lentivirus Infections (8) · Retroviridae Infections (8) · Sexually Transmitted Diseases (8) · Urogenital Diseases (8) · Immune System Diseases (7) · RNA Virus Infections (7) · Sexually Transmitted Diseases, Viral (7) · Virus Diseases (7) · Slow Virus Diseases (2) · Arterial Occlusive Diseases (1)
BID protein, human (2) · Mycophenolic Acid (2) · Cobicistat (1) · Darunavir (1) · Protease Inhibitors (1) · Raltegravir Potassium (1) · Rilpivirine (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · 407 Doctors (1) · A.O. Ospedale Papa Giovanni XXIII (1) · Aghia Sophia Children's Hospital of Athens (1) · Hospitales Universitarios Virgen del Rocío (1) · Medical Research Council (1) · UMC Utrecht (1)
Netherlands (3) · Australia (1) · Italy (1) · Spain (1)
Andy IM Hoepelman, MD (1) · David A Baker, MB ChB (1) · Erik S Stroes, MD PhD (1) · Jan M Prins, MD PhD (1) · Kees Brinkman, MD PhD (1) · Nick Paton, MD (1) · Robert Kauffmann, MD PhD (1) · Robin Soetekouw, MD (1) · Steven FL van Lelyveld, MD (1) · Vana Spoulou (1)
PMID 23646111, PMID 29722823, PMID 29770748, PMID 32129855, PMID 35485333, PMID 37545387